42.39
6.59%
+2.62
Dopo l'orario di chiusura:
42.33
-0.06
-0.14%
Precedente Chiudi:
$39.77
Aprire:
$39.99
Volume 24 ore:
779.16K
Capitalizzazione di mercato:
$445.40M
Reddito:
$1.54M
Utile/perdita netta:
$-44.60M
Rapporto P/E:
-3.8536
EPS:
-11
Flusso di cassa netto:
$-36.10M
1 W Prestazione:
+13.80%
1M Prestazione:
+6.08%
6M Prestazione:
+1,010%
1 anno Prestazione:
+318.46%
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Nome
Corbus Pharmaceuticals Holdings Inc
Settore
Industria
Telefono
617 963 0100
Indirizzo
500 River Ridge Drive, Norwood, MA
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2020-09-08 | Downgrade | BTIG Research | Buy → Neutral |
2020-09-08 | Downgrade | Jefferies | Buy → Hold |
2020-09-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2020-09-08 | Downgrade | ROTH Capital | Buy → Neutral |
2020-07-07 | Iniziato | ROTH Capital | Buy |
2020-06-17 | Iniziato | BTIG Research | Buy |
2020-03-26 | Iniziato | Nomura | Buy |
2019-04-05 | Iniziato | Jefferies | Buy |
2019-03-20 | Iniziato | Oppenheimer | Outperform |
2019-01-11 | Reiterato | Cantor Fitzgerald | Overweight |
2018-12-26 | Iniziato | H.C. Wainwright | Buy |
2018-12-07 | Iniziato | RBC Capital Mkts | Outperform |
2018-10-24 | Iniziato | B. Riley FBR | Buy |
2018-01-19 | Iniziato | Raymond James | Outperform |
2017-12-14 | Reiterato | Cantor Fitzgerald | Overweight |
2017-11-08 | Reiterato | Noble Financial | Buy |
2017-09-29 | Ripresa | Noble Financial | Buy |
2017-03-30 | Reiterato | Cantor Fitzgerald | Overweight |
2016-11-15 | Reiterato | JMP Securities | Mkt Outperform |
2016-11-11 | Reiterato | Noble Financial | Buy |
Mostra tutto
Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire Inc.
Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength
Zacks Investment Research
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
Zacks Investment Research
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire Inc.
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire Inc.
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari
Corbus Pharmaceuticals Holdings Inc (CRBP) Reddito 2024
CRBP ha riportato un ricavo (TTM) di $1.54 milioni per il trimestre terminato 2021-09-30.
Corbus Pharmaceuticals Holdings Inc (CRBP) Reddito netto 2024
CRBP l'utile netto (TTM) è stato di -$44.60 milioni per il trimestre terminato il 2023-12-31, un -5.33% diminuire anno su anno.
Corbus Pharmaceuticals Holdings Inc (CRBP) Flusso di cassa 2024
CRBP ha registrato un flusso di cassa disponibile (TTM) di -$36.10 milioni per il trimestre conclusosi con 2023-12-31, un +3.88% aumento anno su anno.
Corbus Pharmaceuticals Holdings Inc (CRBP) Utile per azione 2024
L'utile per azione (TTM) di CRBP è stato pari a -$10.35 per il trimestre terminato il 2023-12-31, un -1.87% declino anno su anno.
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Cormorant Asset Management, LP | 10% Owner |
Mar 08 '24 |
Buy |
44.38 |
300,000 |
13,314,193 |
2,025,000 |
Cormorant Asset Management, LP | 10% Owner |
Mar 07 '24 |
Buy |
40.05 |
250,000 |
10,013,367 |
1,725,000 |
Cormorant Asset Management, LP | 10% Owner |
Feb 02 '24 |
Buy |
19.00 |
750,000 |
14,250,000 |
1,475,000 |
Cohen Yuval | Chief Executive Officer |
Jan 26 '24 |
Option Exercise |
4.97 |
7,179 |
35,680 |
7,179 |
HOLMER ALAN F | Director |
Jan 26 '24 |
Option Exercise |
4.97 |
629 |
3,126 |
1,379 |
Cormorant Asset Management, LP | 10% Owner |
Jan 26 '24 |
Buy |
32.24 |
282,632 |
9,111,941 |
725,000 |
Capitalizzazione:
|
Volume (24 ore):